Electrophysiological effects and mechanisms of antiarrhythmic action of nibentan in patients with paroxysmal arrhythmias
Golitsin, S.P.
Kardiologiia 43(4): 64-73
2003
ISSN/ISBN: 0022-9040 PMID: 12968607 Document Number: 560521
Document emailed within 1 workday
Related Documents
Kaverina, N.V.; Lyskovtsev, V.V.; Popova, E.P. 2003: Comparative study of electrophysiological mechanisms of anti-arrhythmia IIi class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation Eksperimental'naia i Klinicheskaia Farmakologiia 66(1): 27-33Ribeiro, L.G.; Price, B.A.; Irvin, J.D. 1988: Antiarrhythmic effects of timolol in patients with ventricular arrhythmias Arquivos Brasileiros de Cardiologia 51(4): 359-364
Janse, M.J.; Kléber, A.G.; Downar, E.; Durrer, D. 1977: Electrophysiological changes during acute myocardial ischemia and possible mechanisms for ventricular arrhythmias Annales de Cardiologie et d'Angeiologie 26 Suppl: 551-554
Glushkov, R.G.; Golitsyn, S.P.; Dorodnikova, E.V.; Maĭkov, E.B.; Mashkovskiĭ, M.D.; Merkulova, I.N.; Rozenshtraukh, L.V.; Ruda, M.I.; Skachilova, S.I.; Chazov, E.I.; Iuzhakov, S.D. 1998: The first original Russian class-IIi antiarrhythmic nibentan Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 11: 38-41
Rials, S.J.; Friehling, T.D.; Marinchak, R.A.; Kowey, P.R. 1990: Potassium channels in cardiac arrhythmias: focus on antiarrhythmic drug action Progress in Clinical and Biological Research 334: 111-121
Ledda, F.; Mugelli, A. 1980: Biochemical basis of the electrophysiological mechanisms in arrhythmias in prior subjection to therapy Bollettino Della Societa Italiana di Cardiologia Suppl: 83-90
Seipel, L.; Abendroth, R.R.; Breithardt, G. 1981: Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man Zeitschrift für Kardiologie 70(7): 524-529
Mentz, P.; Förster, W. 1974: Antiarrhythmic effects of prostaglandins F2alpha, E2, and A2 on CaCl2-and aconitine-arrhythmias Acta Biologica et Medica Germanica 32(4): 393-402
Reznik, A.V.; Fedorov, V.V.; Kokoz, I.M.; Korystova, A.F.; Rozenshtraukh, L.V.; Golitsyn, S.P.; Ruda, M.I.; Chazov, E.I. 2003: Ionic mechanisms of cardiotropic action of a new class IIi antiarrhythmic drug RG-2 Kardiologiia 43(10): 76-81
Bjørnstad, H.; Refsum, H. 1991: Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3187-3189
Domenichelli, B.; Manzoli, U.; Schiavoni, G.; Feraco, E. 1974: New method for direct study of antiarrhythmic drugs in man. Electrophysiological effects and criteria for interpretation Minerva Cardioangiologica 22(2): 71-89
Krikler, D.M. 1980: Calcium antagonists: mechanisms of action in arrhythmias Clinical and Investigative Medicine. Medecine Clinique et Experimentale 3(1-2): 29-33
Rabkin, S.W.; Ohmae, M.; Klass, D.J. 1982: Antiarrhythmic effects of cyclic guanosine 3' :5'-monophosphate and sodium nitroprusside on barium chloride arrhythmias in rabbits Archives Internationales de Pharmacodynamie et de Therapie 257(2): 225-238
Fiset, C.; Drolet, B.; Hamelin, B.A.; Turgeon, J. 1997: Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class IIi antiarrhythmic drug dl-sotalol Journal of Pharmacology and Experimental Therapeutics 283(1): 148-156
Grin, J.; Pellizzón, O.A.; Raynald, A. 1996: Mechanisms involved in the antiarrhythmic and proarrhythmic effects of magnesium Medicina 56(3): 231-240
Pritchett, E.L.; Hammill, S.C.; Reiter, M.J.; Lee, K.L.; McCarthy, E.A.; Zimmerman, J.M.; Shand, D.G. 1983: Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia American Journal of Cardiology 52(8): 1007-1012
Kanorskiĭ, S.G. 2014: Antiarrhythmic therapy in patients with paroxysmal and persistent atrial fibrillation: identification of achievable goals and assessment of available funds Kardiologiia 54(2): 70-74
Fomina, I.G.; Minushkin, O.N.; Lidskiĭ, P.I.; Sverchkova, E.I.; Ternovaia, A.S. 1977: Antiarrhythmic action of lidocaine and its side effects Klinicheskaia Meditsina 55(5): 64-70
Alboni, P. 1979: Is an electrophysiological study useful for the choice of anti-arrhythmia drug in patients with supraventricular paroxysmal tachycardia? Giornale Italiano di Cardiologia 9(5): 458-461
Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398